The Global Plasma Protease C1-inhibitor Treatment Market is estimated to be valued at US$ 3,289.5 million in 2020 and is expected to exhibit a CAGR of 18% during the forecast period 2022-2028.
The global plasma protease C1 inhibitor therapy market is expected to witness strong growth in the coming years owing to the increase in acute hereditary angioedema (HAE) and preventive cases. The emergence of several drug variants of C1-inhibitors is considered a major breakthrough for patients suffering from HAE, administered either intravenously or subcutaneously. C1-inhibitors (C1-H) belong to the superfamily of serine protease inhibitors. C1 inhibitors control the activation of the C1 complex. It forms stoichiometric complexes that are proteolytically inactive with C1r or C1s proteases. It also plays an important role in regulating important physiological pathways including complement activation, blood clotting, fibrinolysis and kininogenesis. It is the most effective inhibitor of factor FXIIa and also inhibits chymotrypsin and kallikrein.
(Get 15% Discount on Buying this Report)
A full report of Global Plasma Protease C1-inhibitor Treatment Market is available at: https://orionmarketreports.com/plasma-protease-c1-inhibitor-treatment/83696/
Market Segments
By Drug Type
- C1-inhibitors
- Kallikrein Inhibitor
- Selective Bradykinin B2 Receptor Antagonist
By Dosage
- Lyophilized
- Injectable
Key Players
Key players operating in the global plasma protease C1-inhibitor treatment market include CSL Behring LLC, Takeda Pharmaceutical Company Limited, Ionis Pharmaceuticals, Inc., Pharming Technologies B.V., Centogene AG, BioCryst Pharmaceuticals, and KalVista Pharmaceuticals, Inc.
Scope of the Report
The research study analyzes the global Plasma Protease C1-inhibitor Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Plasma Protease C1-inhibitor Treatment Market Report
1. What was the Plasma Protease C1-inhibitor Treatment Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Plasma Protease C1-inhibitor Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Plasma Protease C1-inhibitor Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Plasma Protease C1-inhibitor Treatment market.
- The market share of the global Plasma Protease C1-inhibitor Treatment market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Plasma Protease C1-inhibitor Treatment market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Plasma Protease C1-inhibitor Treatment market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
